Drug Discovery

The competitive gap between Europe and regions like the United States and China is widening due to administrative delays that slow the deployment of multinational clinical studies. While the European Union possesses world-class healthcare infrastructure, the logistical reality for biotech

The emergence of New Approach Methodologies is driven by both a need for higher scientific accuracy and the ethical considerations surrounding traditional laboratory testing. As drug developers navigate an increasingly complex landscape where costs for a single successful launch often exceed two

With over 1,000 patents filed and nearly 400 papers accepted at global conferences, the institute has already addressed more than 100 distinct industrial challenges. As LG AI Research pushes the boundaries of innovation, the current landscape of industrial research is witnessing a profound

The historical reliance on rigid synthetic substrates for intestinal research has created a significant gap between laboratory observations and the soft, flexible reality of living human tissue. For decades, scientists have struggled to replicate the physiological environment of the gut using

Decoding the intricate architectural history of proteins that has unfolded over billions of years requires a tool capable of bridging the chasm between raw genetic sequences and their complex physical manifestations. The emergence of the Contrastive Learning Sequence-Structure (CLSS) model

By inducing the lysis of malignant cells, oncolytic viruses release a broad spectrum of neoantigens that can prime a patient’s native immune system through a process called epitope spreading. This mechanism represents a significant shift from the current clinical standard of single-target Chimeric